Congcong Lin - Search Results

Year	Number of Results
2013	1
2014	2
2015	2
2016	1
2017	3
2018	4
2019	3
2020	3
2021	4
2022	6
2023	5
2024	1

1

Targeting autophagy-related protein kinases for potential therapeutic purpose.

Xiang H, Zhang J, Lin C, Zhang L, Liu B, Ouyang L. Xiang H, et al. Among authors: lin c. Acta Pharm Sin B. 2020 Apr;10(4):569-581. doi: 10.1016/j.apsb.2019.10.003. Epub 2019 Oct 18. Acta Pharm Sin B. 2020. PMID: 32322463 Free PMC article. Review.

2

Main active components of Si-Miao-Yong-An decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5A-AKT and TLR4-NOX4 pathways in isoproterenol (ISO)-induced heart failure models.

Liao M, Xie Q, Zhao Y, Yang C, Lin C, Wang G, Liu B, Zhu L. Liao M, et al. Among authors: lin c. Pharmacol Res. 2022 Feb;176:106077. doi: 10.1016/j.phrs.2022.106077. Epub 2022 Jan 10. Pharmacol Res. 2022. PMID: 35026404

3

Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives.

Hu J, Zhang D, Tian K, Ren C, Li H, Lin C, Huang X, Liu J, Mao W, Zhang J. Hu J, et al. Among authors: lin c. Eur J Med Chem. 2023 Aug 5;256:115475. doi: 10.1016/j.ejmech.2023.115475. Epub 2023 May 10. Eur J Med Chem. 2023. PMID: 37201428 Review.

4

Medicinal chemistry strategies targeting PRMT5 for cancer therapy.

Fu S, Zheng Q, Zhang D, Lin C, Ouyang L, Zhang J, Chen L. Fu S, et al. Among authors: lin c. Eur J Med Chem. 2022 Dec 15;244:114842. doi: 10.1016/j.ejmech.2022.114842. Epub 2022 Oct 14. Eur J Med Chem. 2022. PMID: 36274274 Review.

5

Novel Medicinal Chemistry Strategies Targeting CDK5 for Drug Discovery.

Tang W, Lin C, Yu Q, Zhang D, Liu Y, Zhang L, Zhou Z, Zhang J, Ouyang L. Tang W, et al. Among authors: lin c. J Med Chem. 2023 Jun 8;66(11):7140-7161. doi: 10.1021/acs.jmedchem.3c00566. Epub 2023 May 26. J Med Chem. 2023. PMID: 37234044 Review.

6

Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics.

Chen Y, Tan L, Gao J, Lin C, Wu F, Li Y, Zhang J. Chen Y, et al. Among authors: lin c. Eur J Med Chem. 2023 Apr 5;252:115306. doi: 10.1016/j.ejmech.2023.115306. Epub 2023 Mar 23. Eur J Med Chem. 2023. PMID: 36996714 Review.

7

Diarylheptanoid: A privileged structure in drug discovery.

Sun DJ, Zhu LJ, Zhao YQ, Zhen YQ, Zhang L, Lin CC, Chen LX. Sun DJ, et al. Fitoterapia. 2020 Apr;142:104490. doi: 10.1016/j.fitote.2020.104490. Epub 2020 Feb 1. Fitoterapia. 2020. PMID: 32017968 Review.

8

Development of JmjC-domain-containing histone demethylase (KDM2-7) inhibitors for cancer therapy.

Zhang L, Chen Y, Li Z, Lin C, Zhang T, Wang G. Zhang L, et al. Among authors: lin c. Drug Discov Today. 2023 May;28(5):103519. doi: 10.1016/j.drudis.2023.103519. Epub 2023 Feb 6. Drug Discov Today. 2023. PMID: 36754142 Review.

9

Advance cardiac nanomedicine by targeting the pathophysiological characteristics of heart failure.

Lin C, Gao H, Ouyang L. Lin C, et al. J Control Release. 2021 Sep 10;337:494-504. doi: 10.1016/j.jconrel.2021.08.002. Epub 2021 Aug 4. J Control Release. 2021. PMID: 34358590 Review.

10

Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy.

Liu Y, Li Y, Wang Y, Lin C, Zhang D, Chen J, Ouyang L, Wu F, Zhang J, Chen L. Liu Y, et al. Among authors: lin c. J Hematol Oncol. 2022 Jul 7;15(1):89. doi: 10.1186/s13045-022-01310-7. J Hematol Oncol. 2022. PMID: 35799213 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

33 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year